Literature DB >> 22742726

Oxygen delivery and fetal-placental growth: beyond a question of supply and demand?

A J Murray1.   

Abstract

Towards the end of the first trimester, blood flow and oxygenation rise within the placenta, supporting an increased capacity for mitochondrial oxidative metabolism in both the placenta and developing fetus. In this regard, the placenta acts uniquely as both a conduit of oxygen to the fetal circulation and a significant consumer of oxygen in order to support its own energy demands for the processes of nutrient transport and protein synthesis for hormone production and growth. When the supply of oxygen becomes restricted, for example during chronic exposure to hypobaric hypoxia at high altitude, placental and fetal tissues respond in order to optimise the allocation of oxygen between competing demands. In this case, the placenta appears to remodel its metabolism to decrease oxygen consumption, probably by increasing ATP production via glycolysis. This process can maintain oxygen supply to the fetus but is still associated with growth restriction. Oxidative stress, a feature of pre-eclampsia, might elicit similar metabolic changes in the absence of hypoxia. This review considers what is known about the metabolic response of the placenta and fetal tissues to hypoxia and oxidative stress, and suggests possible mechanisms that might underlie such metabolic remodelling using lessons from other tissues and organ systems. Aspects of the hypoxia response that remain to be addressed are highlighted and future studies suggested. Much remains unknown about the coordinated metabolic response of the fetal-placental unit to chronic hypoxia and oxidative stress, but it would appear to be more than a simple question of supply and demand.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22742726     DOI: 10.1016/j.placenta.2012.06.006

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  34 in total

Review 1.  Nutrient sensor signaling pathways and cellular stress in fetal growth restriction.

Authors:  Bethany Hart; Elizabeth Morgan; Emilyn U Alejandro
Journal:  J Mol Endocrinol       Date:  2019-02-01       Impact factor: 5.098

2.  Genomics of the fetal hypothalamic cellular response to transient hypoxia: endocrine, immune, and metabolic responses.

Authors:  Charles E Wood; Maria Belen Rabaglino; Eileen I Chang; Nancy Denslow; Maureen Keller-Wood; Elaine Richards
Journal:  Physiol Genomics       Date:  2013-05-07       Impact factor: 3.107

Review 3.  Fetal programming and cardiovascular pathology.

Authors:  Barbara T Alexander; John Henry Dasinger; Suttira Intapad
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

4.  Gestational differences in murine placenta: Glycolytic metabolism and pregnancy parameters.

Authors:  Renee E Albers; Christopher A Waker; Chanel Keoni; Melissa R Kaufman; Michael A Bottomley; Sarah Min; David R Natale; Thomas L Brown
Journal:  Theriogenology       Date:  2017-11-04       Impact factor: 2.740

Review 5.  Placental Origins of Chronic Disease.

Authors:  Graham J Burton; Abigail L Fowden; Kent L Thornburg
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

6.  AMPK activation in pregnant human myometrial arteries from high-altitude and intrauterine growth-restricted pregnancies.

Authors:  Ramón A Lorca; Christopher J Matarazzo; Elise S Bales; Julie A Houck; David J Orlicky; Anna G Euser; Colleen G Julian; Lorna G Moore
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-06-05       Impact factor: 4.733

7.  Placenta as a target of trichloroethylene toxicity.

Authors:  Elana R Elkin; Sean M Harris; Anthony L Su; Lawrence H Lash; Rita Loch-Caruso
Journal:  Environ Sci Process Impacts       Date:  2020-02-05       Impact factor: 4.238

8.  Effects of maternal diabetes and fetal sex on human placenta mitochondrial biogenesis.

Authors:  Shaoning Jiang; April M Teague; Jeanie B Tryggestad; Christopher E Aston; Timothy Lyons; Steven D Chernausek
Journal:  Placenta       Date:  2017-06-06       Impact factor: 3.481

9.  New Insights into the Pathogenesis of Preeclampsia - The Role of Nrf2 Activators and their Potential Therapeutic Impact.

Authors:  N Kweider; C J Wruck; W Rath
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-12       Impact factor: 2.915

10.  Inactivation of maternal Hif-1α at mid-pregnancy causes placental defects and deficits in oxygen delivery to the fetal organs under hypoxic stress.

Authors:  Doreswamy Kenchegowda; Bryony Natale; Maria A Lemus; David R Natale; Steven A Fisher
Journal:  Dev Biol       Date:  2016-12-09       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.